Inner Mongolia Furui Medical Science Co Ltd
SZSE:300049
Inner Mongolia Furui Medical Science Co Ltd
Income from Continuing Operations
Inner Mongolia Furui Medical Science Co Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
I
|
Inner Mongolia Furui Medical Science Co Ltd
SZSE:300049
|
Income from Continuing Operations
¥166.5m
|
CAGR 3-Years
16%
|
CAGR 5-Years
18%
|
CAGR 10-Years
19%
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Income from Continuing Operations
¥6.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
23%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Income from Continuing Operations
¥3.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Income from Continuing Operations
¥3.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
20%
|
CAGR 10-Years
21%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Income from Continuing Operations
¥4.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
1%
|
CAGR 10-Years
13%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Income from Continuing Operations
¥4.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
See Also
What is Inner Mongolia Furui Medical Science Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
166.5m
CNY
Based on the financial report for Mar 31, 2023, Inner Mongolia Furui Medical Science Co Ltd's Income from Continuing Operations amounts to 166.5m CNY.
What is Inner Mongolia Furui Medical Science Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
19%
Over the last year, the Income from Continuing Operations growth was 13%. The average annual Income from Continuing Operations growth rates for Inner Mongolia Furui Medical Science Co Ltd have been 16% over the past three years , 18% over the past five years , and 19% over the past ten years .